Replimune Group, Inc.·4

Feb 14, 4:00 PM ET

Coffin Robert 4

4 · Replimune Group, Inc. · Filed Feb 14, 2020

Insider Transaction Report

Form 4
Period: 2020-02-12
Coffin Robert
DirectorPresident and C.E.O.10% Owner
Transactions
  • Sale

    Common Stock

    2020-02-12$17.04/sh24,250$413,2202,242,368 total
  • Sale

    Common Stock

    2020-02-12$17.03/sh24,250$412,9782,218,118 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
  • [F2]Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,218,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 264,534 of which are exercisable as of the date hereof.

Documents

1 file
  • 4
    a4.xmlPrimary

    4